default author photo

Jing Yu

Nankai University

94 Weijin Road

Tianjin, 300071

China

  • Nankai University

SCHOLARLY PAPERS

2

DOWNLOADS

156

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

GLP-1R Activation by Liraglutide Promotes Breast Cancer Through NOX4/ROS/VEGF Pathway

Number of pages: 29 Posted: 04 Dec 2021
Zhanzhao Liu, Xianxian Duan, Mengci Yuan, Jing Yu, Xiao Hu, Xiao Han, Lan Lan, Bowei Liu, Yue Wang and Junfang Qin
Nankai University, Nankai University, Nankai University, Nankai University, Nankai University, Nankai University, Tianjin Medical University, First Hospital of Qinhuangdao, Nankai University and Nankai University
Downloads 102 (679,608)

Abstract:

Loading...

Glucagon-like peptide-1 receptor (GLP-1R), Reactive oxygen species (ROS), NADPH oxidases 4 (NOX4), VEGF, breast cancer, Liraglutide

2.

EGR3 is Involved in Tamoxifen Resistance in Breast Cancer Cells Through the Modulation of MCL1 Transcription

Number of pages: 24 Posted: 04 Jan 2023
Yu Xie, Xiao Han, Jing Yu, Mengci Yuan, Yan Yan, Junfang Qin, Lan Lan and yue wang
Nankai University - School of Medicine, Nankai University, Nankai University, Nankai University, NanKai University - Tianjin Key Laboratory of Oral and Maxillofacial Function Reconstruction, Nankai University, Tianjin Medical University - Tianjin Medical University Cancer Institute and Hospital and Nankai University - School of Medicine
Downloads 54 (1,020,567)

Abstract:

Loading...

tamoxifen (TAM), endocrine therapy resistance, EGR3, MCL1, estrogen receptor, breast cancer